R&D Trends

Evotec joins NURTuRE Consortium

Wednesday, June 14, 2017

Evotec has joined the NURTuRE consortium to drive kidney disease focused drug discovery based on patient derived-data. NURTuRE is uniquely positioned to collect clinical data at the U.K. Renal Registry and analyze samples of 14 kidney disease centers in the U.K., constituting one of the largest kidney patient registries worldwide.

[Read More]

Irvine Scientific adds new R&D center of excellence

Wednesday, June 14, 2017

Irvine Scientific, a leader in the development and manufacture of cell culture media, announced the expansion of its Orange County, California, offices and laboratories, with the addition of a 40,000 square foot purpose-built R&D center at 17112 Armstrong Ave, Irvine, California. The growth of the company is in response to increased customer demand for Irvine Scientific’s cell culture and media reagents, and follows the significant expansion of its R&D facilities less than five years ago.

[Read More]

Elligo Health Research partners with Consortia Health Holdings

Tuesday, June 13, 2017

Elligo Health Research announced a partnership to grow its clinical research capabilities with Consortia Health. The partnership, which recently commenced patient enrollment for its first study, extends Elligo’s ability to bridge clinical research and clinical health care to accelerate the development of new products and therapies for the pharmaceutical, biotechnology and medical device industries. Recognized as a leader in broadening access to clinical studies for eligible patients, Elligo is the only organization that provides easy access to the 97% of physicians and patients who currently do not participate in clinical research.

[Read More]

iSpecimen launches online marketplace for human biospecimens

Tuesday, June 13, 2017

iSpecimen launched the iSpecimen Marketplace—an online, data-rich platform that connects life science researchers who need human biospecimens to the healthcare organizations that have them. Using a powerful, multi-faceted search platform, the marketplace enables medical researchers to intuitively search millions of available human biospecimens and solves one of the research industry’s biggest challenges—how to compliantly obtain quality biospecimens in a cost-effective manner. Through the marketplace, researchers gain instant access to iSpecimen’s growing, federated network of healthcare providers and biobanks, giving network participants (specimen providers) the opportunity to more broadly contribute to medical research as well as their bottom line.

[Read More]

ReadCoor, WAVE Life Sciences collaborate

Monday, June 12, 2017

ReadCoor, a company reinventing omics and pathology with its panomic spatial sequencing platform, and WAVE Life Sciences, a genetic medicines company focused on developing targeted therapies for patients impacted by rare diseases, announced the initiation of a research collaboration to develop a registry of brain cell network maps and advance WAVE’s nucleic acid chemistry for targeted delivery to the brain.

[Read More]